Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
TEVATEVA(TEVA) Zacks Investment Research·2024-02-01 00:31

For the quarter ended December 2023, Teva Pharmaceutical Industries Ltd. (TEVA) reported revenue of 4.46billion,up14.84.46 billion, up 14.8% over the same period last year. EPS came in at 1.00, compared to 0.71intheyear−agoquarter.Thereportedrevenuerepresentsasurpriseof+12.360.71 in the year-ago quarter. The reported revenue represents a surprise of +12.36% over the Zacks Consensus Estimate of 3.97 billion. With the consensus EPS estimate being $0.75, the EPS surprise was +33.33%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how th ...